101 results
424B1
AXDX
Accelerate Diagnostics Inc
22 Jan 24
Prospectus with pricing info
9:59pm
litigation costs and the results of such litigation;
the expenses we incur in connection with commercialization activities, including product marketing … information could result in regulatory or litigation-related actions against us, legal liability, fines, damages, ongoing audit requirements and other
S-1/A
AXDX
Accelerate Diagnostics Inc
16 Jan 24
IPO registration (amended)
7:18am
related costs, including litigation costs and the results of such litigation;
the expenses we incur in connection with commercialization activities … of personally identifiable information could result in regulatory or litigation-related actions against us, legal liability, fines, damages, ongoing audit
S-1
schw4oe
13 Dec 23
IPO registration
5:30pm
8-K
EX-10.2
l6qf3kdg
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-10.1
xrm2 3keityd4lbw6
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-10.3
xx6lglr7y9 lvtrm
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-10.1
eiv05jau8tucph3h
21 Apr 23
Entry into a Material Definitive Agreement
9:20pm
8-K
EX-10.1
ni76d6snumov w0va
13 Dec 22
Departure of Directors or Certain Officers
5:25pm
8-K
08mk4bqjxcbjw
21 Oct 22
Other Events
4:02pm
8-K
ag289 uu2o
25 Mar 22
Entry into a Material Definitive Agreement
3:00pm
8-K
yw0vh4c
21 Mar 22
Entry into a Material Definitive Agreement
6:06am
8-K
EX-99.2
jwk2nb3l tn
13 Jan 22
Accelerate Diagnostics Announces Preliminary Fourth Quarter & Full-Year 2021 Financial Results
9:16am